Clinical Research Center «BioEq» invites patients to participate in the phase III clinical study of the drug for treatment of patients with nonalcoholic fatty liver disease associated with metabolic syndrome. During the visits, patients will receive regular clinical instrumental examinations: biochemical blood tests and clinical urine tests, screening of autoimmune liver damage, homocysteine level measurement, lipid profile, common urine test, ECG tracing (at all visits), and abdominal ultrasound (at the first and last two visits).
All examinations and medications are provided on a free of charge basis.
We invite men and women starting from 18 years old with:
- Nonalcoholic fatty liver disease
- Metabolic syndrome
- Body mass index 30-45 kg/m2
If you are interested in this research or you have questions about participation, you can contact us during the business days from 10 am to 6 pm at